Gastrin/Cholecystokinin Type B Receptor (CCKBR) Antibody

Este producto es parte de CCK - Cholecystokinin A Receptor
Product Graph
312€ (60 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Gastrin/Cholecystokinin Type B Receptor (CCKBR) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx007382
tested applications
WB

Description

CCKBR Antibody is a Rabbit Polyclonal Antibody against CCKBR.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Gastrin/Cholecystokinin Type B Receptor (CCKBR)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
WB: 1/500 - 1/2000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified by affinity chromatography.
Size 1
60 µl
Size 2
120 µl
Size 3
200 µl
Form
Liquid
Tested Applications
WB
Buffer
PBS, pH 7.3, containing 0.01% thiomersal, 50% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P51959
Gene ID
887
NCBI Accession
NP_795344.1
Alias
CCKBR,CCK2 receptor,CK-B receptor,cholecystokinin-2 receptor ,CHOLREC,gastrin/cholecystokinin type B receptor,CCK-B/gastrin receptor,CCK-2R,CCK-B,CCK2R,GASR
Background
Antibody anti-CCKBR
Status
RUO
Note
Concentration: 1 mg/ml - 

Descripción

CCKBR, also known as CCK2R, is a G protein-coupled receptor (GPCR) that binds both gastrin and cholecystokinin (CCK) peptides, playing critical roles in gastrointestinal function and brain signaling. It is expressed in the stomach, pancreas, brain, and certain tumors. In the gastrointestinal system, CCKBR regulates gastric acid secretion by stimulating parietal cells and promotes gastric mucosal growth, supporting digestive processes. In the central nervous system, CCKBR is involved in modulating anxiety, pain, and satiety through interactions with neurotransmitter systems. Its activation triggers pathways like phospholipase C (PLC), calcium mobilization, and MAPK signaling, leading to cellular proliferation, enzyme secretion, and neuronal modulation. CCKBR is highly implicated in gastric and pancreatic cancers, where gastrin-mediated activation enhances cell proliferation, survival, and tumor progression. Overexpression of CCKBR has been observed in gastric adenocarcinomas, making it a potential therapeutic target. Additionally, dysregulation of CCKBR signaling contributes to gastrointestinal disorders, including peptic ulcers and Zollinger-Ellison syndrome, characterized by excessive gastrin production. CCKBR is also being explored in neuropsychiatric research for its roles in anxiety and pain modulation. Overall, CCKBR regulates digestive and neuronal processes but contributes to disease progression when overexpressed or dysregulated.

Related Products

EH7123

Human CCKBR(Gastrin/cholecystokinin type B receptor) ELISA Kit

Ver Producto
FNab01378

anti- CCKBR-specific antibody

Ver Producto
abx007382

Gastrin/Cholecystokinin Type B Receptor (CCKBR) Antibody

CCKBR Antibody is a Rabbit Polyclonal Antibody against CCKBR.

Ver Producto